Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

By T. King, Janet Tooze, M. Schwarz, K. R. Brown, R. Cherniack. American Journal of Respiratory and Critical Care Medicine, 2001

882 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4b85e5d1f8415794c2f50a2866df78478cfa552f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. H. Collard
2. T. King
3. C. Feghali-Bostwick
4. Ryan T. Kendall

In Pulmonary and Respiratory Medicine

1. H. Collard
2. T. King
3. B. Ley
4. C. Feghali-Bostwick
5. Ryan T. Kendall

Citations in the corpus

• A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. (2015, neutral): “32 du Bois et al 29 assessed numerous risk factors in a large cohort of patients with IPF and developed a practical 4-item risk scoring system that includes age, respiratory hospitalization, percentage predicted FVC, and 24-week change in FVC.”
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011, methodology): “The CRP score is a clinical prediction model that has been developed in IPF (22).”
• Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. (2003, methodology): “Most patients have been previously reported as part of a larger cohort (6).”
• Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (2005, background): “Endexercise hypoxemia during maximal and submaximal steadystate exercise is a useful measure of severity in IPF (9, 10).”
• Fibroblasts in fibrosis: novel roles and mediators (2014, background): ““Fibrocyte” is a term sometimes ascribed to a relatively inactive fibroblast-like cell, whereas the term “fibroblast” designates a fully active cell as described throughout our review.”
• Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity (2005, neutral): “PAH has been shown to significantly affect survival in patients with COPD [20], but this has not been clearly demonstrated in patients with IPF, although evidence of pulmonary hypertension on chest radiograph has been related to a poor prognosis [12].”